NCT04698486View on ClinicalTrials.gov

Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
NAFLD - Non-Alcoholic Fatty Liver DiseaseType 2 Diabetes
Interventions
OTHER

Hyperinsulinemic euglycaemic clamp

"Infusion of constant intravenous insulin to achieve hyperinsulinemia and concomitant infusion of glucose to maintain euglycemia (plasma glucose at 5 mM).~Infusion of palmitate and VLDL-triglyceride tracer. PET/CT scans of heart and liver, both in basal period and during intervention."

Trial Locations (1)

8200

Department of Endocrinology and Internal Medicine, Aarhus N

All Listed Sponsors
collaborator

Danish Diabetes Academy

OTHER

lead

University of Aarhus

OTHER

NCT04698486 - Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD | Biotech Hunter | Biotech Hunter